Pre-eclampsia surgery: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
|||
| Line 2: | Line 2: | ||
{{Pre-eclampsia}} | {{Pre-eclampsia}} | ||
{{CMG}} {{AE}} {{Sara.Zand}} | {{CMG}} {{AE}} {{Sara.Zand}} | ||
==Overview== | |||
== Delivery == | == Delivery == | ||
[[Delivery]] is the mainstay of therapy for [[preeclampsia]] in the 37 weeks of [[gestation]] or occurrence any of the following:<ref>{{cite journal|title=Gestational Hypertension and Preeclampsia|journal=Obstetrics & Gynecology|volume=135|issue=6|year=2020|pages=e237–e260|issn=0029-7844|doi=10.1097/AOG.0000000000003891}}</ref> | [[Delivery]] is the mainstay of therapy for [[preeclampsia]] in the 37 weeks of [[gestation]] or occurrence any of the following:<ref>{{cite journal|title=Gestational Hypertension and Preeclampsia|journal=Obstetrics & Gynecology|volume=135|issue=6|year=2020|pages=e237–e260|issn=0029-7844|doi=10.1097/AOG.0000000000003891}}</ref> | ||
| Line 27: | Line 28: | ||
[[Category:Emergency medicine]] | [[Category:Emergency medicine]] | ||
[[Category:Cardiology]] | [[Category:Cardiology]] | ||
Revision as of 02:35, 25 October 2020
|
Pre-eclampsia Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Pre-eclampsia surgery On the Web |
|
American Roentgen Ray Society Images of Pre-eclampsia surgery |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Sara Zand, M.D.[2]
Overview
Delivery
Delivery is the mainstay of therapy for preeclampsia in the 37 weeks of gestation or occurrence any of the following:[1]
- Repeated episodes of severe hypertension(blood pressure≥ 160/110 mmHg, despite maintenance treatment with 3 classes of antihypertensive agents
- Progressive thrombocytopenia
- Progressively abnormal renal or liver enzyme tests
- Pulmonary edema
- Abnormal neurological features, such as severe intractable headache, repeated visual scotomata,convulsions,Visual disturbances, motor deficit, alteredsensorium
- Stroke
- Myocardial infarction
- HELLP syndrome (hemolysis,elevated liver enzymes,low platelet)
- Eclampsia
- Suspected acute placental abruption or vaginal bleeding in the absence of placenta previa
- Abnormal fetal testing
- Fetal death
- Fetus without expectation for survival at the time of maternal diagnosis (lethal anomaly, extreme prematurity)
- Persistent reversed end-diastolic flow in the umbilical artery
References
- ↑ "Gestational Hypertension and Preeclampsia". Obstetrics & Gynecology. 135 (6): e237–e260. 2020. doi:10.1097/AOG.0000000000003891. ISSN 0029-7844.